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Weanling male Sprague-Dawley rats were randomly fed three different diets (n=8 per 
group), a control diet (AIN '93) (C), a blueberry diet (B) for 13 weeks and a reverse diet 
(R)(C for 13 weeks, switched to B for 8 weeks). Aortae were excised, rings were 
prepared, and two intact and two denuded rings were immersed in tissue baths containing 
physiological salt solution (PSS) at 37OC, aerated with 95% 0 2  and 5% CO2 (pH 7.4). 
Following equilibration and pre-conditioning under 1 Sgm preload, cumulative dose 
response curves were generated with six doses of the a-1 adrenergic receptor agonist L- 
Phenylephrine (L-Phe, 1 O-' to 3 XI o-~M). Relaxation was induced in the rings with 
Acetylcholine (Ach, 3 x ~ o - ~ M ) .  Effective denudation was assessed by the absence of 
relaxation to Ach and the maximal contraction and relaxation force (Fmax) was 
determined. Intact arterial rings had a significantly lower Fmax than denuded rings 
( 0 . 9 6 9 ~  vs. 3 . 0 7 6 ~ )  (Pc0.05). Mean Fmax of intact rings for C, B, and R groups 
were 1.109, 0.873 and, 0.926gm (SEM=0.0463) respectively. A two-way ANOVA 
demonstrated that B and R groups had a lower Fmax than C group when contracted with 
L-Phe (pc0.05). There were no significant differences in Fmax means of denuded rings 
among diet groups (p<0.05). Our results indicate for the first time that whole wild 
blueberries function through the endothelium to influence the contractile machinery of 
the rat aorta in response to an a-1 adrenergic receptor agonist. 
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CHAPTER 1 
INTRODUCTION 
Cardiovascular Disease (CVD) has plagued developed countries as the primary 
cause of death for the past two decades accounting for nearly half of all deaths among the 
United States adult population (1). Approximately 60 million people in the United States 
have CVD with half of these individuals having no history of the disease (2, 3). CVD 
occurs as a result of continuous damage to the dynamic and delicate vascular 
endothelium that constitutes the inner layer of blood vessels (4, 5). The arterial integrity 
is determined by the condition of the endothelium. Potentially, it is the compilation of 
the various damaging factors that compromise the structural integrity of the artery (6- 10). 
A dysfunctional vascular endothelium can be triggered by hypercholesterolemia, 
hyperhomocysteinemia, hypertension or smoking (4). 
Blueberries, containing polyphenols and other antioxidants, have the highest 
antioxidant capacity of all fruits and vegetables. The possible roles of dietary flavonoids 
and antioxidants are currently being examined in a variety of in vitro studies. The results 
thus far have determined that polyphenols and antioxidants have beneficial effects on 
maintaining the integrity of the vascular endothelium in vitro (1 0, 12, 13). In addition, 
previous in vitro studies confirmed the beneficial effect of blueberry fractions on the 
biomechanical properties of the artery (13). Pilot studies recently conducted in Dr. 
Klimis-Zacas's laboratory determined that whole wild blueberries affect the mechanical 
properties of the arteries (1 1). The pilot study results determined that blueberries 
decrease the maximum force developed by the artery when challenged with the a- 1 
antagonist, phenylephrine. However, whole wild blueberries do not affect the cell 
membrane receptors, as indicated by the vessel reactivity. As a result, the mechanisms 
by which blueberries affect the artery may involve the endothelium or smooth muscle I 
cells. The role of whole wild blueberries as a functional food, with respect to their site 
and their mechanism of action on the endothelium, can only be evaluated and fully 
understood through an in vivo study. 
This project is a dietary study examining the effect of whole wild blueberries on 
the biomechanical properties of the artery in vivo and its relationship to cardiovascular 
disease. Sprague-Dawley rats will be fed diets with and without blueberries. The passive 
and active properties of the vascular endothelium will be studied with the use of tissue 
force analyzers. Animals intact and denuded arteries will be studied from all diet groups. 
Denudation, removes the endothelial layer of cells from the artery. Thus, denudation, 
mimics the damage that occurs to an artery with CVD. This data will provide the first 
information on the role of whole bluebemes as a functional food with respect to arterial 
integrity and CVD. This data will provide insight to blueberries' mechanism of action on 
the endothelium with respect to CVD. Ultimately, the results of this research will also 
indicate the possible implications whole wild blueberries may have on blood pressure 
regulation. 
The objectives of this thesis are: 
1. To evaluate the role of whole wild bluebemes on the biomechanical properties (Fmax 
and pDz) of the Sprague-Dawley rat artery. 
2. To determine the site of the action of whole wild blueberries on the artery (smooth 
muscle vs. endothelium) 
CHAPTER 2 
LITERATURE REVIEW 
2.1 Cardiovascular Disease 
Even though the most recent medical advances and educational intervention 
tactics have decreased the overall rate of cardiovascular disease (CVD) cases, CVD 
continues to claim more lives in developed countries each year than any other disease (1). 
More than 2,600 Americans die each day from CVD (2). Consequently, CVD causes one 
death every thirty-three seconds (3). Approximately, one in five people have some form 
of cardiovascular disease (4). CVD will cost the United States an estimated $35 1.8 
billion in 2003 in health expenditures and lost productivity (5). The manifestations of 
CVD include angina pectoris, chronic heart failure, coronary artery disease, myocardial 
infraction, stroke, ischemic stroke and hypertension (6). CVD occurs as a result of 
chronic endothelial inflammation, the trademark of atherosclerosis. Chronic inflammation 
creates a dysfunctional endothelium and can be attributed to a variety of risk factors such 
as: smoking, high concentrations of oxidized low-density lipoprotein (LDL), diabetes, 
hypercholesterolemia, hyperhomocysteinemia, low levels of high-density lipoprotein 
(HDL) and hypertension (7, 8). Physical inactivity, poor nutrition and being overweight 
or obese are additional factors that can increase an individual's risk of CVD (6). 
However, only 30% of CVD cases can be related to traditional risk factors (2-4). 
Consequently, in order to decrease deaths related to CVD, a greater focus needs to be 
dedicated to the prevention of CVD. 
2.2 Endothelium and the Vascular Smooth Muscle Cell 
The etiology of cardiovascular disease is based on the structural integrity and 
health of the vessels of the cardiovascular system. The walls of an artery consist of the 
intima, media, and adventitia (9). The intima, the innermost layer of the artery wall, is 
contains a single layer of endothelial cells. The amorphous mucopolysaccharide ground 
substance containing elastin, collagen, and vascular smooth muscle cells (VSM) is 
referred to as the media layer. The VSM is composed of actin and myosin and undergoes 
tonic contractions initiated by mechanical, electrical and chemical stimuli. The 
adventitia, consisting of connective tissue, is the outermost layer surrounding the two 
inner layers (1 0, 9). 
The endothelium functions as the modulator of cardiovascular health by balancing 
the vasoconstriction and vasodilatation of the artery. The vascular homeostasis achieved 
by modulatory role of the endothelium occurs through mediators that act to affect the 
musculature and vasculature of the artery (9). The vascular muscle activity of the aorta 
affects its permeability to various vasoactive substances by directly regulating the 
elasticity and distensibility of the aorta's vascular wall (1 1). The endothelium relays the 
message of vasoactive substances by serving as a communication medium between the 
blood and the VSMC. The vasoactive substances alter the vascular tone of the artery 
through myogenic mechanisms, endothelial factors, local hormones or chemical 
substances, and metabolic by-products. Consequently, signal transmission causes muscle 
contraction or muscle relaxation and can occur through numerous pathways involving 
nerve signals, blood-borne substances and locally generated substances (12). 
Vasoactive substances functioning in the pathways act as vasoconstrictors or 
vasodilators. Vasoconstrictors typically bind to receptors on the VSMC or endothelium I 
and can elicit a contraction. Angiotensin 11, vasopressin, endothelin- 1, norepinephrine 
and thromboxane A2 are examples of vasoconstrictors (13, 14, 9). Vasodilators include 
nitric oxide/endothelium derived relaxing factor (EDRF), endothelium-derived 
hyperpolarizing factor, C-type natriuretic peptide and kinins. Acetylcholine causes 
vasodilation through pathways involving NO, PGI2, and EDRF production (1 5, 16). 
Vasorelaxation is stimulated by the release of the EDRFNO and can also be stimulated 
by ATP, histamine, bradykinin, and other agents (10, 17). Vasodilators function to 
protect the integrity of the artery by inhibiting VSMC growth, platelet aggregation, 
platelet thrombosis, monocyte adhesion, inflammation and adhesion (7, 18). The 
appropriate balance between vasoconstriction and vasodilation is maintained by a 
functional endothelium and allows for a healthy cardiovascular system. The effect of 
various vasoactive substances is illustrated in Table 2.1. 
Table 2.1: The Effect of Vasoactive Substances on the Endothelium 
Vasodilators Vasoconstrictors 
Nitric Oxide 
Prostacyclin 
Atrial Natriuretic Peptide 
C-type Natriuretic Peptide 
Kinins 
Endothelium-derived 
Hyperpolarizing factor 
Angiotensin I1 
Endothelin 
Vasopressin (Anti-diuretic hormone) 
Cytokines 
Thrombin 
Oxygen Free Radicals 
Shearing Forces 
Adapted from Klabunde et a1 and Hsueh et a1 (7, 12) 
The autonomic nervous system, composed of the sympathetic and 
parasympathetic systems, can regulate the flow of blood based on the degree of vascular 
tone present in the artery. The a- 1 and a-2-adrenergic receptors, located in the aorta's 
VSMC, bind with agonists to cause vasoconstriction (1 0, 19). Vasoconstriction occurs via 
the sympathetic nervous system due to the activation of noradrenaline or norepinephrine 
and subsequent binding to a-adrenoreceptors (9). An agonist is a substance that interacts 
with receptor molecules to produce an effect identical to the endogenous signaling 
molecule. For instance, phenylephrine is an alpha-1 adrenergic agonists for 
norepinephrine that can elicit a contraction (20,21). Whereas an antagonist, is a 
substance that binds to a receptor, competes with the hormonal signal and prevents the 
response of the hormonal signaling molecule (9). 
Also located in the blood vessels are P-adrenergic receptors that inhibit 
contraction and cause vasorelaxation in the VSMC (9). Acetylcholine, released into 
circulation by the parasympahthetic nervous system, causes vasoconstriction under 
resting vascular tone and vasodilatation under raised vascular tone (20). The effect of 
acetylcholine is termed biphasic because its effect is based on the level of vascular tone. 
Acetylcholine affects pathways of vasoactive substances including factors such as NO, 
PG12 and EDRF (16, 22). The degree of relaxation that occurs in the presence of 
agonists binding the P-adrenergic receptors is based upon the degree of contraction 
present in the artery. In other words, for relaxation to occur a certain level of contraction 
must be present in the artery. In addition, P-adrenergic receptors also experience 
desensitization that causes their effects to diminish with increased exposure to agonists 
(1 0, 17, 21). Consequently, vascular tone of the artery determines the effect that the 
parasympahthetic nervous system has on blood flow. 
Alpha and P receptors can be present in the same vessel and also share the same 
neurotransmitter, norepinephrine (9). The a and P effect of norepinephrine is based on 
receptor affinity. Typically the a receptor has the highest affinity for norepinephrine and 
causes a contraction. Beta-receptors generally have a higher affinity for epinephrine than 
norepinephrine and elicit a relaxation (1 7). There are a variety of biologically active 
substances that bind specifically to various cell receptors of the aorta initiating a complex 
cascade of events (23) capable of causing a relaxation or contraction. Ultimately, the 
contraction or relaxation induced by the binding of a neurotransmitter or agonists has on 
the artery's vasculature depends on several known and even unknown factors. The effect 
is dependent upon the vascular tone present in the artery, the vasoactive substance 
binding the receptor and the effect the cascade of events have on the calcium 
concentration in the VSMC (21). 
Ultimately, neurotransmitters and vasoactive substances affect the concentration 
of intracellular calcium via signal transduction mechanisms and determine the VSMC 
contraction. Increases in intracellular calcium cause calcium to bind to calmodulin, a 
special calcium binding protein (9). The binding of calcium to calmodulin forms a 
calcium-calmodulin complex and causes the activation of the enzyme myosin light chain 
kinase (MLCK). With ATP, MLCK causes the phosphorylation of myosin light chain 
(MLC), resulting in the formation of a cross-bridge between myosin and actin and a VSM 
contraction (22). Calcium concentrations are regulated by the phosphatidyinositol 
pathway, G-protein-coupled pathway, and nitric oxide-cGMP pathway (24). The 
complexity of the pathways influencing VSMC contraction is illustrated in Figure 2.1. I 
Figure 2.1: Signal Transduction Pathways Affecting Vascular Tone in the VSMC 
, 
NE 
AII 
ET-1 
NE: norepinephrine, AII: angiotensin 11, ET- 1 : endothelin-I, PL-C: phospholipase 
C, PIP2: phosphatidylinositol, IP3: inositol triphosphate, SR: sarcoplasmic reticulum, 
DAG: diacylglycerol, PK-C: protein kinase C, P2: P receptor, Epi: epinephrine, Gs: G 
protein pathway stimulated, Gi: G protein pathway inhibited, AC: adenyl cyclase, NO: 
nitric oxide, GC: guanyl cyclase, MLCK: myosin like chain kinase, Ca: calcium, GTP: 
guanyl triphosphate, GDP: guanyl diphosphate, CAMP: cyclic adenosine monophosphate, 
ATP: adenosine triphosphate. Klabunde et al. 2002 (1 2) 
Nitric Oxide (NO), the most important vasodilating substance, previously was 
referred to as endothelium derived relaxing factor (EDRF) (9). The role of nitric oxide is I 
central to the modulatory function of the endothelium. The vascular protective functions 
of NO include; vasodilation, inhibiting sympathetic vasoconstriction, inhibiting platelet 
and leukocyte adhesion to the endothelium, inhibiting VSM proliferation, preventing 
thrombosis and scavenging superoxide aninon to prevent inflammation (1 3, 16, 25). 
Nitric oxide is produced in the endothelial cell from the oxidation of L-arginine to L- 
citrulline by nitric oxide synthase (NOS). Nitric oxide synthesis is presented in figure 
2.2. 
Figure 2.2: Nitric Oxide Pathway 
Endothe tia l 
Cell 
Smooth 
Muscle Cell 
Klabunde et al. 2002 (12) 
Nitric oxide synthase has three isoforms, NOS-1, NOS-2, and NOS-3. Neural 
NOS (nNOS) or NOS-I and endothelial NOS (eNOS) or NOS-3 are present during 
baseline physiological conditions (N20). Inducible NOS (iNOS) or NOS-2 is expressed 
during inflammatory physiological states (26, 27). Nitric oxide, produced in the 
endothelial cell, activates guanyl cyclase in the VSM to increase concentration of cyclic- 
GMP. The increased cGMP is capable of activating cGMP-dependent protein kinase. 
Activation of the protein kinase stimulates the following pathway; inhibition of calcium 
entry into the VSM, decreased calcium-calmodulin MLCK binding, decreased 
phosphorylation of myosin light chains, reduced contractile forces and vasodilation. The 
mechanism of NO- induced relaxation is portrayed in Figure 2.2 (9). Acetylcholine, 
bradykinin, substance-P, insulin, and histamine stimulate the production of NO by 
increasing the calcium concentration. Also, shear force created by blood flow can result 
in calcium release and cause eNOS to increase the production of NO. Inducible NOS is 
capable of increasing NO production in the presence of cytokines and bacterial 
endotoxins. Each of these mechanisms that increase NO production serve an important 
function in the cardiovascular system. The effect of NO is based on its production and 
bioavailability. The bioavailability can depend upon the presence of reactive oxygen 
species, intracellular availability of L-arginine, altered NOS activity and impaired 
receptor mediated release of NO (6, 12, 14). Along with the protective and regulatory 
role of NO, the cardiovascular system also possesses a series of defense mechanisms. The 
antioxidant defense mechanisms that function to prevent damage are composed of 
antioxidant enzymes and include; superoxide dismutase (SOD), catalase, gluthione 
peroxidase and glutathione reductase (9). In addition, glutathione, a-tocopherol and 
ascorbic acid are free-radical scavengers that help to maintain arterial integrity (6,28). 
2.3 Cardiovascular Disease and Endothelial Dysfunction 
The health of the cardiovascular system is determined by the condition of the 
endothelial cells. Various circulating factors have the potential to impair the modulatory 
role of the endothelial cells and cause vascular injury and disease. Consequently, 
cardiovascular disease is characterized by a dysfunctional endothelium. As the modulator 
of cardiovascular health, the endothelium controls platelet aggregation, fibrinolysis, 
vascular tone, growth, immune responses, smooth muscle cell proliferation and thrombus 
formation (9). Each of these components has the potential to cause inflammation and 
create a dysfunctional endothelium (13, 8). The endothelium functions to maintain 
vascular homeostasis and tone through paracrine mediators by regulating the 
vasodilatation and vasoconstriction of the artery. Paracrine mediators are vasoactive 
substances that only affect the target cells in close proximity to the cell releasing the 
mediators. A dysfunctional endothelium causes a disruption in the delicate balance of 
paracrine mediators regulating the vasoconstriction and vasodilatation (8). A disruption 
in the balance of paracrine mediators regulating the vascular endothelium, causes a loss 
of normal anti-platelet activity, vasodilator or anti-thrombotic activity, increases the 
potential the likelihood of vasospasm, thrombiosis or further inflammatory damage (29). 
Consequently, the role of the endothelium is to balance the dilation and contraction of the 
artery in order to maintain the arterial integrity. 
Inflammation, a multi-factorial process that causes a dysfunctional endothelium, 
is the main characteristic associated with the development and progression of 
atherosclerosis (8). Atherosclerosis is a form of CVD and is characterized by chronic 
inflammation. Cellular and molecular responses to the chronic inflammation cause the 
development and progression of arterial lesions. Initially, inflammatory stimuli cause the 
up-regulation of surface and soluble cell adhesion molecules and the release of cytokines 
(1 3). During inflammation platelets release pro-inflammatory mediators including 
thromboxane A2 and serotonin (30). Early atherosclerotic events include the adhesion of 
platelets and monocytes to the endothelium. This process is referred to as the activation 
of the endothelium and is the initial event in the atherosclerotic process. Injury to the 
arterial wall from chronic inflammation results in the disruption of the physiological 
protective regulatory balance of the endothelium, another factor in the development of 
atherosclerosis. Growth factors are then released from platelets, endothelial cells, 
macrophages, and VSMC that further enhance the inflammatory process (3 1). Continued 
inflammation results in the enhanced release of hydrolytic enzymes, cytokines, 
chemokines, and growth factors from the activated endothelium. The release of these 
factors attracts circulating monocytes that then bind to adhesion molecules and migrate 
into the subendothelial space. Lipid-laden foam cells or fatty streaks develop from 
monocyte-derived macrophages that scavenge oxidized LDL and migrate into the 
subendothelial space. As the process is augmented, VSMCs migrate and extracellular 
debris, lipids, and cholesterol crystals are deposited around the lesion. The deposition of 
calcium is followed by necrosis of the foam and endothelial cells. The fibrous plaque 
formed, is composed of the core lipid and necrotic tissue. Hemorrhage and thrombosis 
characterize the final stages of atherosclerosis (6, 8, 31). 
Oxidative stress contributes to the atherosclerotic process and occurs when there 
is an imbalance between in vivo antioxidant defense mechanisms and the production and 
exposure of cells to reactive oxygen species (ROS) and reactive nitrogen species (RNS). 
Superoxide, hydroxyl, peroxyl, oxides of nitrogen, and peroxynitrite are all examples of 
reactive oxygen and nitrogen species that can cause oxidative stress (32). These free 
radical species can oxidize LDL particles (33). Thus, the atherosclerosis process can also 
be initiated and intensified by the oxidized LDL trapped within the lesion. The oxidative 
modification hypothesis and the research supporting this hypothesis provide the evidence 
that links CVD to the inflammation caused by oxidized LDL (34). A high concentration 
of plasma LDL particles results in the increase of both circulating monocytes adhering to 
the arterial wall and to a higher concentration of LDL particles entering the intima. 
Consequently, there is an increased chance of the LDL particle to become oxidized. In 
vitro studies discussed by Steinberg et al., state that foam cell formation occurs from 
macrophages/monocytes and smooth muscle cells that bind modified or ox-LDL (35). In 
addition, Tapiero et al. discussed in vitro studies that determined the simple incubation of 
LDL overnight with endothelial cells or smooth muscle cells created a foam cell, 
providing yet another mechanism by which LDL could hnction in foam cell formation 
(9, 35). Also, Noguchi et al. recently completed research indicating that ox-LDL not only 
damages the endothelium physically, but ox-LDL also induces a variety of pro- 
atherosclerotic genes (28). It is widely accepted that oxidized LDL play a critical role in 
the atherosclerotic process by exerting several harmful effects on the endothelium (36). 
Oxidized LDLs' cytotoxic effects include, increasing the production of growth factors, 
inhibiting the release of NO and increasing leukocyte adhesion to endothelial cells (36). 
In humans, both observational and experimental studies have demonstrated an 
association between inflammation and endothelial dysfunction (8). Researchers have 
concluded that there are morphological and functional changes in the endothelial cells 
located in areas prone to atherosclerosis (37). Endothelial cells that undergo these 
changes have impaired dilation and have a diminished protective role against the 
atherosclerostic process (37). Goode et al. concluded through an in vitro study that 
human hypercholesterolemic peripheral arteries exhibit vascular abnormalities because of 
impaired endothelial function (38). Ishibashi et al. observed vascular abnormalities 
manifested by an impaired endothelium that affected forearm blood flow among patients 
with congestive heart failure (39). Numerous other studies have established two primary 
associations regarding the impaired functioning of the cardiovascular system. First, 
studies have confirmed an association between low-grade inflammation and 
atherogenesis (29). The second association is a relationship between acute systemic 
inflammation and increased risk for a cardiovascular event (29). Hingorani et al. 
determined a relationship in humans between endothelial dysfunction and risk of CVD, in 
the presence of a Salmonella typhi vaccine. The vaccine created a mild inflammatory 
event and the researchers observed impaired endothelium dependent vasodilation among 
the human subjects (29). These studies are only a few of the numerous studies that 
document the association between inflammation, endothelial dysfunction and risk of 
cardiovascular disease. 
Along with impairment of endothelial function, hyperesponsiveness of the 
vascular smooth muscle can also lead to endothelial damage, vascular injury and disease. 
Hyperresponsiveness of the VSMC can potentially cause enhanced vasoconstriction. 
Atherosclerosis and hypertension enhance the contractile effects of the artery and tend to 
predispose a patient to myocardial ischemia (38, 39). In addition atherosclerosis and 
hypertension are risk factors for myocardial infraction. However, atherosclerosis and 
hypertension reduce endothelium dependent responses to acetylcholine, bradykinin, 
thrombin and platelet derived products causing enhanced contractile effects. Goode et al. 
determined that hypertension and atherosclerosis in animal and human subjects enhanced 
the contractile effects of serotonin (38). Hyperresponsiveness of the VSMC or 
impairment of the endothelium are capable of affecting the integrity of the artery and the 
endothelium derived relaxation. Denudation, removal of the intima layer of the 
endothelium, mimics the arterial damage that occurs during atherosclerosis and impairs 
the release of EDRF/NO. 
EDRF/NO is produced by the endothelial cell and relaxes VSMC by activating 
guanylate cyclase to form cyclic GMP by protein phosphorylation. NO activity is 
responsible for vasodilation, lowering of blood pressure, inhibition of platelet 
aggregation, inhibition of platelet and leukocyte adhesion to the vascular endothelium, 
inhibition of VSMC proliferation and scavenging superoxide anions (12). Thus NO can 
function as a superoxide scavenger by reacting with superoxide anion to form 
biologically inactive nitrate. On the other hand, NO and superoxide can also form 
peroxynitirite radical which can form a hydroxyl radical (33). Peroxynitrite is capable of 
causing oxidative damage associated with the pathogenesis of inflammatory disease (40). 
Thus, the biological activity of NO to function as an oxidant or oxidant scavenger is 
based on the intracellular formation of superoxide anion. 
The role of NO is central in the regulation and the pathogenesis of cardiovascular 
diseases (41). The dysfunctional endothelium of atherosclerotic arteries impairs the 
synthesis, release and functions of EDRF/NO (9). Many diseases and conditions have 
been associated with decreasing the production of nitric oxide and impairing 
endothelium-dependent vasorelaxation. Hypertension, atherosclerosis, diabetes, obesity, 
dyslipidemias, heart failure, cigarette smoking, aging and vascular injury are diseases or 
conditions known to damage the endothelium and reduce the expression of eNOS (1 2, 
42). Normal release of NO through the eNOS reaction is responsible for physiologic 
vasodilation. However, studies have determined that during septic shock, NO production 
through iNOS is possibly responsible for regulation of blood pressure and endogenous 
antioxidants (4 1). Numerous experiments have indicated that EDRF/NO is decreased in 
the beginning of the atherosclerotic process and decreased NO production has been 
observed to be a mechanism responsible for the endothelial dysfunction (9). Impairment 
of NO production can cause thrombosis from platelet aggregation and adhesion, 
inflammation from tissue damage by ROS, vascular stenosis or vasoconstriction (12). A 
correlation was shown by Cleland et al. between basal endothelial NO synthesis and low- 
grade inflammation (8). Thrombosis, myocardial infraction and reperfusion injury are 
cardiovascular complications that have been observed to have an impaired production 
and effect of NO (43). Nitric oxide production is also affected by pathologies damaging 
the endothelium, hypoxia, or trauma (44). Consequently, disruption in the NO function, 
has been widely implicated in creating a dysfunctional endothelium and being a crucial 
factor in the progress of cardiovascular disease (43). 
2.4 Blueberries 
2.4.1 Composition of Blueberries 
Lowbush blueberries, Vaccinium angustifolium, also referred to as whole wild 
bluebemes, are commonly referred to as antioxidant powerhouses. The components of 
low bush blueberries are water, carbohydrates, eleven minerals and five vitamins (45). 
Bushway et al. determined that niacin, riboflavin, thiamin, vitamin C and vitamin A are 
the five vitamins found in blueberries (45). The minerals are calcium, potassium, 
magnesium, phosphorus, aluminum, boron, copper, iron, manganese, sodium, and zinc 
(45). Despite the antioxidant vitamin content of bluebemes, Prior et al. concluded that 
the polyphenolic compounds of blueberries contribute substantially to their antioxidant 
capacity (46). Polyphenolic compounds consist of phenolic acids, their esters and 
flavonoids. Blueberries have been determined to have the highest oxygen radical 
absorbance capacity (ORAC) of all h i t s  and vegetables (47,48). Prior et al. confirmed 
a direct correlation between the total ORAC and the total polyphenolic content of various 
blueberries (49). Kalt et al. reported that lowbush blueberries, Vaccinium angustifolium, 
have higher concentrations of anthocyanins, total phenolics and ORAC than the species 
of high bush "cultivated" blueberries (48). 
Polyphenols function as reducing agents and can function to regenerate other 
antioxidants, such as vitamin E. The antioxidant capacity of polyphenols is provided by 
phenolic group's ability to function as hydrogen donors. The polyphenolics posses an 
aromatic ring bearing one or more hydroxyl substituents. Polyphenols also posses metal- 
chelating properties that possibly allow them to decrease iron and copper induced 
oxidations (50). 
Among the flavonoids are the flavans, flavonols, proanthocyanidins, and 
anthocyanins. Kalt and McDonald determined that chlorogenic acid is the major 
phenolic acid in the low bush blueberry. Other major organic acids include citric (36%), 
malic (3 1%) and quinic (20%) (5 1). The major flavonols found in blueberries are 
kaempferol and quercetin (52). Proanthocyanins, higher molecular weight component of 
the blueberry, are a type of tannin found in bluebemes that have been shown to inhibit 
the initiation stage of chemically induced carcinogenesis (53). Five major anthocyanins 
have been reported in the lowbush blueberry. The five anthocyanins, delphinidin, 
malvidin, petunidin, cyanidin and peonidin, are shown in figure 2.3 and table 2.2 (54). 
The anthocyanins in the lowbush blueberry are found as their 3-glucosides, 3- 
galactosides and 3-arabinosides. According to Prior et al., the total anthocyanin content 
of lowbush blueberries is 95.4 * 2.6 mg/l OOg of bluebemes (49). Based on a 1976 study 
conducted by Kuhnau et al., the estimated average U.S. American anthocyanin intake was 
180 g in the winter and 21 5 g in the summer (55). Tsuda et al. explained the variation in 
favonoid stating that human consumption of flavonoid ranges from 25 mg/day to 
lmg/day (56). According to Marchand et al., flavonoid intake varies among different 
countries from 3 mg in Finland to 68 mg in Japan (56). 
Figure 2.3: The Flavylium Cation. R1 and R2 are H, OH, or 0CH3; R3 is a glycosyl or 
H; and R4 is OH or a glycosyl. Excerpted from Kong et al. (57) 
Table 2.2: Five Major Anthocyanidins Reported in the Vaccinium angustifolium 
OH: hydroxyl, H: hydrogen, OMe: methyl 
Excerpted from Kong et al. (57) 
Name 
Cyanidin 
Delphinidin 
Malvidin 
Peonidin 
Petunidin 
Abbreviation 
Cy 
Dp 
My 
Pn 
Pt 
7 
OH 
OH 
OH 
OH 
OH 
3' 
OH 
OH 
OMe 
OMe 
OMe 
4' 
OH 
OH 
OH 
OH 
OH 
3 
OH 
OH 
OH 
OH 
OH 
5' 
H 
OH 
OMe 
H 
OH 
5 
OH 
OH 
OH 
OH 
OH 
Color 
Orange-red 
Bluish-red 
Bluish-red 
Orange-red 
Bluish-red 
6 
H 
H 
H 
H 
H 
Although in the past, information on bioavailability has been referred as being 
scarce, researchers have recently made considerable contributions to the areas of 
flavonoid absorption, metabolism and excretion in humans and rats. Numerous 
researchers have observed the absorption of flavonoids from poly-phenolic rich foods 
across the gut barrier by obtaining measurements of the plasma antioxidant capacity 
before and after consumption (46, 57). Most recently, Kay et al. observed the ORAC and 
total antioxidant status (TAS) of eight men's plasma who had consumed 100 g of fieeze- 
dried blueberries with a high fat meal in a single blind cross-over study. Kay et al. 
determined that the diet-induced ex vivo increase in serum antioxidant status, was 
directly associated with the observed in vitro antioxidant content of blueberries (58). The 
antioxidant activity observed is influenced by the absorption of the flavonoid. According 
to Heim et al. the absorption is affected by the mode of administration, antecedent diet, 
dosage amount, gender differences, and colonic microflora (59). For instance, iron and 
protein may bind flavonoid hydroxyl groups and hinder their absorption (60). 
The structure of the flavonoid affects the absorption mechanism and the 
biological benefits of the metabolized flavonoid. Flavonoids naturally occurring in plants 
exist mostly as glycosylates rather than as aglycones, the form with the sugar moiety 
removed. However, until recently most research on flavonoid absorption was conducted 
on aglycones. The glycosylation of the sugar affects the absorption, metabolism and 
biological benefits of the flavonoid (52). Flavonoids containing sugars can be 
hydrolyzed at the brush border allowing the aglycones to diffuse across the cell 
membrane. Flavonoids with sugar moieties may also cross the enterocyte border via the 
sodium-dependent glucose transporter. Regardless of absorption, cleavage of the 
glycosides by the cytosolic P-glycosidase can occur (52). Flavonoids are conjugated in 
the intestinal cells and bound to albumin for transport to the liver (30). In the liver, the 
flavonoid can be further conjugated with methylation or sulfation. The extent of 
conjugation is associated with the biological capacity of the flavonoid. For instance, in a 
review paper Nijveldt et al. hypothesized that the extent of conjugation is directly related 
to decreased toxicity, antioxidant activity and enzyme inhibiting capacity of the flavonoid 
(30). Mananch et al. demonstrated that continuously high intakes of the flavonoid 
quercetin in rats decreased absorption but increased the formation of the conjugated form, 
which has more antioxidant activity than the aglycone form (61). Paganga and Rice- 
Evans et al. confirmed that dietary flavonoids were absorbed as glycosides by identifying 
the presence of anthocyanins, rutin, and quercetin glycosides in human plasma through an 
in vivo study (62). The investigation confirmed that a polyphenolic plasma concentration 
required to attain 50% of maximal relaxation, 0.5-1.6 pmol/L, was detected in human 
subjects. Miyazawa et al. also confirmed the intestinal absorption, in humans, of orally 
administered anthocyanin extracts, cyanidin glucosides, and the subsequent increase in 
plasma concentration and antioxidant capacity (62). However, Wu et al. was unable to 
detect anthocyanins in the plasma of six women who consumed a 189 g of low bush 
blueberries as a meal. Wu et al. concluded that the anthocyanins were poorly absorbed 
and that only 0.004% of the l89g consumed was detected in the urine 6 h later (63). 
Tsuda et al. investigated the in vivo mechanism for the absorption and metabolism of 3-0- 
P-D-glucoside (C3G) in rats. After the oral administration of 0.9rnrnolkg 3-0-P-D- 
glucoside body weight the following mechanism was purposed (56). First, C3G is 
hydrolyzed by P-glucosidase in the intestines and the aglycones of cyanidin (Cy), C3G, 
is produced and degraded to protocatechuic acid (PC). Consequently, the free form C3G, 
observed in the previously discussed studies on rats and humans, may improve the 
antioxidant activity of this flavonoid (56). Numerous studies have confirmed the 
absorption of anthocyanin intact glycoside forms by detection in plasma and urine. 
Thus, more research is needed to understand the absorption, metabolism, biological 
benefiting mechanisms and excretion of dietary flavonoids in both humans and rats. 
The role of blueberries in disease prevention and treatment can be attributed to 
their ORAC value, among other beneficial components (47,48). The metabolites of 
polyphenolic compounds produced during the digestion provide the blueberries with the 
high ORAC value. The high ORAC value allows the blueberries to protect the body from 
oxidative stress. According to Scalbert et al., the health benefits associated with 
blueberry consumption may correlate with the polyphenolic concentration and functions 
(46). Currently, research has indicated that blueberries have possible health benefit's in 
protecting against chronic diseases and include, preventing glaucoma, fibrocystic disease 
of the breast in humans, cancer, cerebrovascular conditions, diabetes, atherosclerosis, and 
cardiovascular disease (30). The anthocyanins, delphinidin and cyanidin, have also been 
identified as having other therapeutic effects acting as radiation-protective agents, 
vasotonic agents, chemoprotective agents, hepatoprotective agents and anti-inflammatory 
agents (47). Anthocyanins have also been postulated to function in the treatment of 
microcirculation disease and prevention of cholesterol-induced atherosclerosis in the 
rabbit (47). 
The vast majority of the research conducted thus far has been on the polyphenolic 
extracts of blueberries rather than on the whole wild blueberry itself. The research 
conducted on the extracts has been mostly in vitro (61, 68). Consequently, the role of 
whole wild blueberries in preventing various chronic diseases is accepted because of the 
high ORAC value of the blueberry's polyphenolic components. Blueberries are potential 
candidates in disease prevention and treatment, however, in vivo research is lacking and 
further studies are critical to understand their benefits on human health (48). 
2.4.2 Flavonoids 
Flavonoids have been documented to have beneficial effects as antioxidants, 
antiviral, anticancer, anti-inflammatory, anti-allergic and anti-atherogenesis components 
through in vitro experiments (30,64). According to Schramm and German flavonoids 
may function to protect vascular health by the following mechanisms: free radical 
termination, protease inhibition, inhibition of the Maillard reactions, growth suppression 
of bacteria and prevention of leukocyte adhesion (65). Flavonoids have been proven to 
inhibit the atherosclerotic process in many animal studies (66). Aviram et al. examined 
the effect of pomegranate juice (PJ) on the atherosclerotic process in human subjects and 
atherosclerotic apolipoprotein e-deficient mice. PJ contains the following anthocyanins: 
cyanidin-3-glucoside, cyanidin-3, 5-diglucoside and delphindin-3-glucoside. Aviram 
concluded that PJ decreased LDL susceptibility to aggregation in humans and in mice PJ 
reduced oxidation of LDL by 90%, reduced uptake of oxidized LDL by 20%, reduced the 
size of atherosclerotic lesions by 44% and the formation of foam cells. This study 
concluded that in atherosclerotic mice and humans PJ antioxidative properties provide 
antiatherogenic effects (67). Consequently, flavonoids have potential effects in 
improving vascular health by reducing platelet aggregation, improving capillary 
permeability, reducing leukocyte adhesion, oxidative stress, and improving vasodilation 
of the arteries (68). 
Bravo et al. summarized the possible protective mechanisms of flavonoids to 
reduce free radical formation, protect alpha tocopherol in LDL from oxidation, increase 
regeneration of oxidized alpha tocopherol and chelating metal ions (50, 59). Flavonoids 
are potent antioxidants that function as oxidizing species scavengers, neutralizing 
superoxide anion, hydroxyl radicals, peroxy radicals or as quenchers of a reactive oxygen 
species (59,69, 70). Flavonoids react with free radicals to terminate the propagating 
chain reaction (71). The in vitro antioxidant capacity of flavonoids is directly related to 
the degree of hydroxylation. Another antioxidant mechanism determined by Arora et al. 
is the ability of flavonoids is to decrease membrane fluidity and stabilize membranes 
(72). 
Flavonoids have been observed to function in twenty- four enzyme systems. 
VanHoorn et al. investigated the effect of flavonoids on xanthine oxidase, an enzyme that 
increases during periods of oxidative stress (64). During the re-oxidation of xanthine 
oxidase, both harmful superoxide radicals and hydrogen radicals are produced. VanHoorn 
et al. determined that flavonoids with hydroxyl groups located at the 5 and 7 position on 
the flavone backbone possessed the strongest xanthine oxidase inhibitory effect (64). 
Other effects flavonoids have on the enzyme systems include pathways involving; cell 
division, platelet aggregation, detoxification, inflammatory and immune responses (73, 
74). The inhibitory effects of flavonoids are associated with enzymes involved in cell 
activation including, protein kinase C, protein tyrosine kinase and phospholipase A2 (75). 
Smith et al. conducted an assay used to detect cancer preventive action and determined 
that flavonoids from wild bluebemes inhibit the initiation stage of chemically induced 
carcinogenesis (53). There is also substantial experimental evidence regarding the action 
of flavonoids in various cancer-related biological pathways. The cancer-related pathways 
that flavonoids affect include; carcinogen bioactivation, cell signaling, cell cycle 
regulation, angiogenesis, oxidative stress and inflammation (74). Studies on a variety of 
flavonoid sources have determined that the flavonoid and antioxidant content in red wine, 
black tea, green tea, fruit juices and chocolate can function to inhibit LDL oxidation (66, 
67, 68, 76, 77, 78 79). 
The structure of flavonoids is directly associated with the ability of the flavonoid 
to function as an antioxidant or prooxidant. Galati et al. determined that polyphenolics 
containing a polyphenolic ring are more prooxidant than polyphenolics containing a 
catechol ring (80). According to Skibola et al. the result of excessive flavonoid intake 
causes the flavonoid to function as a mutagen, pro-oxidant and inhibitor of key enzymes 
(8 1). Further research is needed to elucidate the potentially toxic effects associated with 
excessive flavonoid intake and the intake levels that cause these effects. The antioxidant 
functions of flavonoids pertain to their ability to scavenge radicals, scavenge the high 
concentrations of nitric oxide created by macrophages via nitric-oxide synthase, and 
inhibit xanthine oxidase activity causing less oxidative damage (69). 
Flavonoids have been implicated to have a preventive role in a number of 
inflammatory and disease processes including; asthma, cancer, cardiovascular disease, 
cataracts, diabetes, gastrointestinal inflammatory diseases, liver diseases, macular 
degeneration and periodontal disease (82). Figure 2.1 presents the hypothetical effects of 
flavonoids on disease mechanisms. 
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Figure 2.4: Hypothetical Mechanisms of the Role of Flavonoids on Diseases 
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2.4.3 Anthocyanins 
Anthocyanins, the most abundant flavonoid found in blueberries, are located 
within the outer layer of the blueberry and are responsible for the blue pigmentation of 
the blueberry. The Greek origin of the word anthocyanin is anthos, which means flower, 
and kyanos, which means blue. Anthocyanins, a phenolic phytochemical, are found 
throughout the plant kingdom and in the diet as crops, beans, fruits, and vegetables and in 
red wine (30,40). Anthocyanins found in the lowbush blueberry, as presented in Figure 
2.3 and table 2.2, include delphinidin, malvidin, petunidin, cyanidin, and peonidin (54). 
Although blueberries contain ascorbic acid, it is their anthocyanin content that is 
attributed to providing their high antioxidant capacity (53). 
Tsuda et al. investigated the anti-oxidative, radical scavenging and lipid 
peroxidation inhibitory effects of three anthocyanins extracted from Phaseolus vulgaris. 
The three anthocyanins, pelargonidin 3-O-P-D-glucoside (P3G), cyanidin 3-0-P-D- 
glucoside (C3G), and delphinidin 3-O-P-D-glucoside (D3G) are three of the five 
anthocyanins found in lowbush blueberries. In addition, the aglycones, pelargonidin 
chloride (pel), cyanidin chloride (Cy) and delphindin chloride (Del) antioxidative activity 
were evaluated. The anti-oxidative activity was evaluated as reduced malondialdehyde 
by UVB radiation in a liposomal system. Each extract demonstrated strong antioxidative 
activity, but the radical scavenging and antioxidative activity were associated with each 
pigments structure (83). Other studies by Tsuda et al. documented that anthocyanins 
have antioxidant ability under physiological conditions during both in vivo and in vitro 
experiments (40). Tusda et al. concluded that the anthocyanin, cyanidin, is readily 
absorbed and metabolized in rats and was found to create a high serum antioxidant 
capacity (40). Antioxidant activity of anthocyanins was determined based on effects on 
LDL oxidation and the lecithin liposome system in vitro by Gracia et al. (73). Gracia et 
al. determined that the ability of the anthocyanin extracts to inhibit oxidation increased as 
follows; pelargonidin < cyaniding < delphinidin < malvidin. The researchers determined 
that the antioxidant capacity of anthocyanins is affected by the metabolic system, the 
substrate and conditions used to catalyze the oxidation (73). Gabrielska et al. revealed 
that anthocyanin extracts of honeysuckle and chokeberry function reduced LDL oxidation 
in vivo (84). Frank et al. recently documented the effect of dietary anthocyanins ability 
to spare vitamin E in healthy rats in vivo (85). Other studies have determined the 
antioxidative activity of anthocyanins to be concentration and dose dependent (40, 84). 
In 1976, Kuhnau et al. documented for the first time that anthocyanins can 
function in metal chelation (55). Further research by numerous investigators, has 
concluded that anthocyanins function as inhibitors of lipid peroxidation, as free radical 
scavengers or in biological systems through metal chelation or protein binding (73, 83). 
Sarma et al. identified that anthocyanins chelate metal ions to prevent the oxidation of 
ascorbic acid by forming an ascorbic metal anthocyanin complex (86). 
Various studies have confirmed the biological effect of anthocyanin extracts. 
Joseph et al. discovered that anthocyanin extracts are important in neurological 
functioning. They determined in numerous studies that anthocyanin extracts can decrease 
the occurrence of the parameters commonly associated with several age-related neural 
dysfunction conditions and cognitive decline (87). Obi et al. concluded that anthocyanin 
extracts from N rosasinensis administered to rats prevented carbon-tetrachloride induced 
liver damage (88). Anthocyanins cyanidin (Cy) and delphinidin (Del) have been found 
to inhibit tyrosine kinase activity of epidermal growth-factor receptor and inhibit growth 
of human tumor cells in vitro by Meiers et al. (89). Other research has confirmed the 
effect of anthocyanins on anti-inflammatory activity, anti-convulsant activity, antioxidant 
activity, and anti-carcinogenic activity (73). Studies have documented the antioxidant 
capacity of anthocyanins to contribute to the following biological effects; decreased 
capillary permeability and fragility, reduced platelet aggregation and strengthening the 
collagen matrix of connective tissue (68). 
2.5 Cardiovascular Disease and Blueberry Components 
2.5.1 Dietary Intake and Cardiovascular Disease 
Multiple mechanisms are capable of functioning to activate the vascular wall and 
thus compromise the arterial integrity of the vascular system. Epidemiological, 
observational, and experimental studies have produced a substantial amount of evidence 
linking the consumption of antioxidant containing fruits and vegetables to reduced risk of 
cardiovascular disease or improved cardiovascular health (32). According to Morton et 
al. the antioxidant content, including b-carotene, vitamin C, vitamin E and the 
polyphenolics, are responsible for reducing the risks of CVD and cancer (32). The Seven 
Countries Study, conducted by Hertog et al., evaluated the association between flavonoid 
intake and CHD among 16 cohorts, from seven different countries, in men between 65-84 
years of age from 1960 to 1985 (90). Average flavonoid intake and mortality rates were 
inversely related with 90% of the variance explained by saturated fat intake and smoking. 
Hertog et al. investigated flavonoid intake and mortality associated with coronary heart 
disease (CHD) in one of the six cohorts from the Seven Countries Study, the Netherlands 
cohort, in an epidemiological survey called "The Zutphen Elderly Study" (91). The 
sources of flavonoids were tea, onions, and apples with the daily average flavonoid intake 
being 25.9 mg. The findings of the Zutphen Elderly Study determined inverse 
relationships between flavonoid intake and mortality from CHD (p=0.015) and incidence 
of myocardial infarction (p=0.08). In addition, the result of the Zutphen Elderly Study, 
revealed a dose dependent association between flavonoid intake and CHD mortality (91). 
Knekt et al. determined a weak inverse relationship between flavonoid intake and CHD 
among 5 130 Finnish men and women over a 20-year period (92). On the other hand, 
Rimm et al. in the U.S. Health Professionals Follow-up Study identified a very weak 
inverse relationship between flavonoid intake and total CHD (93). However, this study 
that found a poor correlation between CHD and flavonoid intake only evaluated the 
presence of CHD, not mortality rates from CHD. In conclusion, although 
epidemiological and observational studies are not conclusive they indicate the potential 
benefits of flavonoid consumption with respect to CVD (V). More recently, 
epidemiological evidence regarding the intake of red wine, principally composed of 
polyphenolic compounds, has generated the concept of the "French Paradox" (94). The 
red wine consumption among the French population may be partially responsible for the 
reduced incidence of CHD among the French population. Hayek et al. determined that 
mice deficient in apolipoprotein E, which spontaneously develop atherosclerosis, had 
significantly reduced lesion development when fed red wine or quercetin (95). 
Yamakoshi et al. determined that proanthocyanidin extract from grape seeds inhibited 
atherosclerosis lesion development in cholesterol-fed rabbits (96). 
Observational studies have identified flavonoids as having a protective effect 
against CVD. Later studies discussed the in vitro role of flavonoids and have revealed 
the protective antioxidant activity of phenolic compounds (32). However, researchers 
postulate that some cardiovascular benefit of polyphenolic consumption may be 
independent of polyphenolic antioxidant capacity and attributed to the endothelium-NO 
dependent relaxation through the NO-cGMP pathway. Regardless, current research 
efforts are being directed towards understanding the mechanisms and identifying both the 
individual dietary plant compounds and whole functional foods that may protect against 
CVD. 
2.5.2 Adhesion and Aggregation 
Flavonoids affect platelets, monocytes and VSMCs through a variety of 
mechanisms that directly influence the cardiovascular system (30). According to a 
review by Harborne et al., flavonoids have been demonstrated to affect cardiovascular 
health by inhibiting platelet adhesion to the endothelial wall, aggregation, and secretion 
(30). Up-regulation of inflammatory mediators, platelet aggregation and endothelial 
adhesion are critical steps in the atherosclerotic process. During inflammation, 
arachidonic acid is released and metabolized by platelets to form thromboxane A2 which 
causes platelet aggregation and adhesion. Activated platelets release pro-inflammatory 
mediators and can inhibit the development of nitrous oxide and prostacyclin (69). 
Aggregation of platelets can cause stenosis, impede blood flow and result in a thrombosis 
(30). 
Flavonoids have been implicated to affect multiple pathways and considered to 
have antithrombotic and antiaggregatory properties. Youdim et al. concluded that 
anthocyanins have implications in preventing vascular disease by protecting against 
oxidative insult based on a study that demonstrated that vascular endothelial cells can 
incorporate anthocyanins. Following a four hour incubation, anthocyanin extracts from 
the elderberry were incorporated into the membrane and cytosol of endothelial cells (97). 
In yet another study, Youdim et al. evaluated the antioxidant and anti-inflammatory 
effects of blueberry and cranberry anthocyanins and hydroxycinnamic acids in human 
endothelial cells. Berry phenols reduced up-regulation of inflammatory mediators and 
responses to inflammatory insults (tumor necrosis factor a) that result in the attraction of 
leukocytes and endothelial damage. Furthermore, berry phenols were protective at the 
endothelial cell membrane and cytosol against inflammatory insults, oxidative stress and 
may be protective components in the development of vascular diseases (98). 
Friesenecker et al. determined that flavonoids reduced the number of leukocytes adhering 
to the endothelium during an arterial injury, which reduces the inflammatory response 
(99). Tzeng et al. determined that flavonoids prevent thromboxane formation which 
results in reduced platelet aggregation and adhesion (100). Numerous studies have 
documented that flavonoids can also inhibit platelet aggregation by stimulating adenylate 
cyclase activity (71). 
Chung et al. evaluated the effect of quercetin and kaempferol derivatives on 
platelet aggregation from various stimuli in the rabbit model. The results indicated that 
both quercetin and kaempferol derivatives function to inhibit the platelet aggregation in 
vitro (101). According to Melzig et al. kaempferol, a flavonoid found in blueberries, was 
determined to prevent the action of deaminase, an enzyme responsible for adenosine 
inactivation, in rat aortic endothelial cells (102). Zaragoza et al. determined through an 
in vitro study examining the effects of the bilberry, that platelet aggregation was inhibited 
by a solution of 30 mg/ml of bilberry anthocyanins (103). Bilberry contains four of the 
five anthocyanins found in the whole wild blueberry. Freedman et al. evaluated the in 
vivo and in vitro effect of purple grape juice and purple grape juice derived flavonoids 
among 20 healthy male subjects with respect to cardiovascular disease and endothelial 
integrity. The researchers discovered that platelet aggregation was reduced with the oral 
supplementation and also during the in vitro trials. In addition, NO production was 
increased and superoxide production was decreased in both trials. Therefore, positive 
cardiovascular effects were observed both in in vitro and in in vivo studies with purple 
grape juice (104). Thrombin-induced platelet aggregation and platelet activity in 
thrombosis were decreased in rats fed grape polyphenolics (32). Numerous other in vitro 
studies determined that anthocyanins reduce capillary permeability, prevent platelet 
aggregation, and thrombus formation, which are all, associated with CVD (97, 98). 
The antithrombotic and antiaggregatory activities of flavonoids are related to their 
structure. Flavonoids' ability to inhibit platelet aggregation, by inhibiting CAMP, is 
dependent upon the following: a double bond between C-2 and C-3, a 3-OH group, and a 
carbonyl group at C-4. According to research conducted by Robak et al., flavonoid 
glycosides and flavanone derivatives are not able to impair platelet aggregation. 
Chemical characteristics that impede the ability of a flavonoid to effect platelet 
aggregation are: saturation of the double bond between C-2 and C-3, glycosylation at C-3 
and polyhydroxylation. Consequently, the inhibitory effects of flavonoids are determined 
by the structural composition of the flavonoid (71). 
2.5.3 Endothelium-dependent Vasorelaxation and Nitric Oxide 
The vascular endothelium regulates vascular tone and blood flow through 
responses to vasoactive stimuli and shear stress (1 05). Vasorelaxation assists in 
preventing adhesion of platelets and reducing blood flow, which can affect the formation 
of a lesion. The release of endothelium derived substances, including NO and EDHF, 
produce endothelium dependent vasorelaxation. The reduced vasorelaxation observed 
with a dysfunctional endothelium in various vascular pathologies is attributed to a 
reduction in NO production and release (105). Thus, NO has been proven to play a 
pivotal role in endothelial dysfunction (1 05, 106, 107). 
Flavonoids from various fruits, vegetables, nuts, teas and herbs have been 
implicated in inducing endothelium-dependent vasorelaxation through a variety of 
mechanisms (105). Andriambeloson et al. investigated the endothelial-NO dependent 
effect of anthocyanin enriched blueberry extracts in vitro on rat aortic rings. The results 
determined that the delphinidin, but not malvidin or cyanidin, enriched blueberry extract 
induced an endothelial-NO dependent vasorelaxation. With endothelial removal or 
suppression of NO synthesis via inhibitors, the relaxation mechanism was suppressed. 
Consequently Andriambeloson et al. concluded that, the mechanism utilized in the 
delphinidin-induced vasorelaxation was completely mediated by NO (1 05). 
Andriambeloson et al. then observed the in vitro vasodilatory effect of red wine 
polyphenolic compounds (RWPC) on NO induced vasorelaxation in rat aortic rings. The 
RWPC induced endothelial-NO dependent vasorelaxation function by increasing the 
production and release of NO and cyclic-guanosine 3', 5-monophosphate (1 06). 
Andriambeleson et al, postulated that although flavonoids have been observed to reduce 
the oxidation of lipids, the mechanism involved in RWPC induced vasorelaxation is 
possibly based on the inhibition of cyclic nucleotide phosphodioesterase rather than on 
the protection of NO from oxidative stress (106). Andriambeloson et al. also compared 
the in vitro endothelium-dependent vasorelaxant activity of the individual RWPC 
extracts, polymerized flavanols and anthocyanins of RWPC (105). Results of this study 
revealed the anthocyanin extracts were more potent in inducing endothelium-dependent 
relaxation than the oligomeric condensed tannins (105). In addition, the anthocyanin 
delphinidin, an anthocyanin found in blueberries, was shown to induce 89% vessel 
relaxation in vitro. On the hand, malvidin and cyanidin, two other anthocyanins found in 
blueberries, did not induce vasorelaxation in vitro (105, 106). The endothelium- 
dependent vasorelaxation effect observed with the anthocyanin extracts and the 
individual delphinidin extract was mediated entirely by NO and comparable to the effect 
observed with the original RWPC (106). Fitzpatrick et al. observed in vitro NO- 
endothelium-dependent vasorelaxation of the rat-precontracted aorta during exposure to 
RWPC, grape juice polyphenolics and grape skin polyphenolics (107). Muzutani et al. 
evaluated the in vivo effect of RWPC on blood pressure and the biomechanical properties 
of stroke-prone hypertensive rats. The rats were fed RWPC for 8 weeks and Muzutani et 
al. observed reduced blood pressure and improved arterial biomechanical properties 
(1 08). In conclusion, the anthocyanin extracts, particularly delphinidin, of both RWPC 
and blueberries, elicit endothelial-NO dependent vasorelxation in vitro in rat aortic rings 
(105). Furthermore, these studies indicate the endothelial-NO dependent relaxation of 
aortic rings is caused by an extracellular dependent calcium mechanism that activates NO 
synthase. The vascular relaxation effect observed with polyphenolic compounds, with 
respect to CVD, is most likely associated with the increases in NO production through 
the NO-cGMP pathway and independent of their anti-oxidant effect (32, 105, 106, 107). 
Lebeau et al. revealed encouraging results through an in vivo study in which rharnnoside 
quercetin rich diets, reduced myocardial post-ischemic damage in rats (109). Tsuda et al. 
fed rats cyanidin 3-0-P-D-glucoside (C3G) and observed an increased resistance to liver 
ischemia-reperfusion injury. The C3G increased the serum thiobarbituric acid-reactive 
substance (TBARS) indicating that C3G has in vivo antioxidant functions (1 10). 
Djousse et al. examined the effect of red wine consumption with a high fat 
meal on the postprandial endothelial function of 13 healthy human subjects by evaluating 
flow-mediated dilation of the brachial artery. High fat meals may acutely impair 
endothelium-dependent vasodilation. The results did not indicate a significant difference 
in flow-mediated dilation with the consumption of red wine (1 11). Sanae et al. studied 
the effects of eight catechin derivatives on the vascular tone of intact and denuded rat 
thoracic aortas. The catechin derivatives were determined to inhibit the endothelium 
dependent relaxation by inhibiting NO activation and impairing the response of guanylate 
cyclase in VSMC. Consequently, Sanae et al. concluded that the catechin derivatives 
potentiated the contractile response to phenylephrine observed in intact rat thoracic aorta, 
and diminished the response in denuded rat thoracic aorta (1 12). 
2.6 Cardiovascular Health and Whole Wild Blueberries 
Blueberries, containing polyphenols and other antioxidants, have the highest 
antioxidant capacity of all fruits and vegetables (48, 49). Numerous studies have 
investigated the effect of polyphenolic extracts from flavonoid containing foods or the 
activity of individual anthocyanin extracts. However, the vast majority of the studies 
conducted thus far, has been in vitro or ex vivo, with only a few evaluating the effects of 
anthocyanin extracts in vivo. In addition, there are very few studies that have evaluated 
the role of whole wild lowbush blueberries (Vaccinium Angustfolium) in the etiology of 
cardiovascular disease. Research on flavonoids implicates that flavonoids found in 
blueberries could potentially improve vascular health by reducing platelet aggregation, 
improving capillary permeability, reducing leukocyte adhesion and oxidative stress and 
enhancing endothelial-NO dependent vasodilatation of the arteries (68). 
Increased serum antioxidant status among human subjects following consumption 
of lowbush blueberries (Vaccinium Angustfolium) has been documented. Kay et al. 
investigated the effect of whole wild blueberries (Vaccinium Angustifolium) on 
postprandial antioxidant status in humans as related to chronic degenerative diseases. 
ORAC and total antioxidant status were used to evaluate the serum antioxidant status of 
eight middle-aged men following a high fat meal and a control supplement and then a 
high fat meal and a blueberry supplement. The blueberry supplement consisted of 100 g 
freeze-dried blueberry powder. The results revealed that the blueberry supplement 
caused a diet-induced increase in ex vivo serum antioxidant status (58). Kay et al. 
observed an ex vivo increase in antioxidant status among eight human subjects following 
a one week supplementation with 100 gramslday freeze dried blueberry powder (58). 
Mazza et al. confirmed an increase in serum antioxidant status in five male subjects 
following consumption of 100 g of freeze-dried blueberry powder (Vaccinium 
Angustifolium) (1 13). Consequently, there is an association between the in vitro and 
dietary ex vivo antioxidant properties of blueberries. According to Aviram et al. serum 
antioxidant status and the development of chronic degenerative diseases are inversely 
related (67). 
Blueberries and red wine are obviously not the only dietary sources containing 
anthocyanins. In fact, anthocyanins and polyphenolics found in numerous h i t s  and 
vegetables contribute to the concentrations of anthocyanins in human plasma. Studies 
have been conducted to compare anthocyanin plasma values in humans with the plasma 
concentration needed to induce relaxation. The effective concentration of plasma 
anthocyanins required to induce 50% of maximal endothelium dependent relaxation 
(E&), the ECso concentration, in humans is 1-10 pmol1L. Paganga and Rice-Evans 
evaluated non-supplemented humans and found steady-state plasma concentrations of 
anthocyanins to be 0.5-1.6 pmol1L (62). This observed anthocyanin plasma 
concentration is within the EC50 value and implies that human plasma concentrations can 
attain the amount needed to induce 50% of a maximal vessel relaxation. According to 
Cao et al., peak serum antioxidant status in humans occurs 60 to 70 minutes following 
consumption (1 14). Consequently, this evidence further enhances the possible 
therapeutic role of dietary anthocyanins particularly those found in whole wild lowbush 
blueberries (1 05). 
Pilot studies in Dr. Klimis-Zacas's laboratory, as documented by Kalea et al. and 
Norton et al. determined the effect of whole wild blueberries on the biomechanical 
properties of the artery using the Sprague-Dawley rat model, as related to cardiovascular 
disease (1 1, 1 15). They determined that blueberries added to the diet of Sprague Dawley 
rats decreased the maximum contraction in response to alpha-1 adrenergic agonists in the 
rat aorta. This is the first time whole wild blueberries incorporated into animal diets 
showed an in vivo effect on the biomechanical properties of the arteries. 
This research project is significant for two very unique reasons. One it is the first 
time the role of dietary whole wild blueberries and their effects on the mechanical 
properties of the arteries is being investigated. Hence, the study is one of the first in vivo 
studies conducted to examine the health benefits of incorporating blueberries into a daily 
diet. Second, this is one of the only nutritional projects worldwide utilizing the scientific 
technology of tissue force analyzers to unravel a nutritional problem. The tissue force 
analyzer is a highly sensitive and novel instrument being used in physiological 
experiments. Tissue force analyzers allow us to relate the physiological properties of 
arterial rings to their biomechanical properties. Consequently, this technology will allow 
the effects of blueberries on the mechanical properties of denuded and intact arterial rings 
to be studied as they relate to CVD. 
2.7 Objectives 
1. To evaluate the role of whole wild blueberries on the biomechanical properties (Fmax 
and pDz) of the arteries of the Sprague-Dawley rat. 
2. To determine the site of the action of whole wild blueberries on the artery (smooth 
muscle vs. endothelium) 
CHAPTER 3 
MATERIALS AND METHODS 
3.1 Animal Models 
The experimental protocols and procedures for handling rats were approved by 
The Institutional Animal Care and Use Committee of the University of Maine. Weanling 
male Sprague-Dawley rats were obtained from the Charles River Laboratories 
(Wilmington, MA). The animals were randomly assigned to one of three diet groups and 
housed in conditions previously described (Taylor et al., 1996). The animals were 
weighed weekly and provided with free access to food and tap water. The three diet 
groups were the blueberry (B), AIN-93 control (C) and reverse (R) diet group. The B and 
C group diet study were each fed for a period of 13 weeks. The R diet group consumed 
the AIN-93 control diet for 13 weeks and then the blueberry diet for a period of 8 weeks. 
Please refer to Table 3.1 for the Experimental Design of the Diet Study. 
Table 3.1: Diet Groups 
Diet Group Name 
Control Group 
1 Reverse Group I AIN-93 diet 1 13 weeks 
Blueberry Group 
I AIN-93 diet plus blueberries 1 8 weeks 
Diet Composition 
AIN-93 diet 
AIN-93 diet plus blueberries / l 3  weeks 
Duration on Diet 
13 weeks 
3.2 Diet Composition 
Diet composition is presented in Table 3.2. The diets were composed of dextrose, 
egg white solids, vitamin mix, D-L-Methionine, biotin, mineral mix (lgmlkg), and corn 
oil. All purified ingredients were purchased from Harlan Teklad (Madison, WI), with the 
exception of the mineral mix that was purchased from ICN Biomedicals (Aurora, OH). 
Whole wild bluebemes were purchased as a composite of bluebemes from Wymans 
(Cherryfield, ME) and freeze dried with standard procedures by the American 
Lyophilizer Inc. (Bridgeport, PA). A blender was used to grind the freeze dried 
bluebemes to a fine powder. Food intake among diet groups did not differ as determined 
by Kalea et al. (1 1). 
Table 3.2: Diet Composition 
Dietary Component 
Dextrose 
Egg white solids 
Blueberries 
Biotin 1 0.002 
Control Diet 
691 g 
Vitamin mix 
D-L-Methionine 
Blueberry Diet 
61 1g 
200 g 
o g  
200 g 
80 g 
10 g 
4 g 
Mineral mix (1 g/kg Mn) 
10 g 
4 g 
35 g 
Total 1000 g 1000 g 
3.3 Drugs and Solutions for the Surgical Procedure 
Salts for the Physiologic Salt Solution (PSS in rnM: NaCl 118, KC1 4.7, CaC12.5, 
MgS04 1.2, KH2P04 1.2, NaHC03 12.5, glucose 1 1 .I), acetylcholine chloride and L- 
phenylephrine were purchased from Sigma (St. Louis, MO, USA). 
3.4 Preparation and Mounting of Rat Aortic Rings 
At the end of the feeding period, each animal was fasted for 10-12 hours prior to 
the beginning of each experiment. Each animal was sacrificed with the administration of 
2 to 3 minutes of C 0 2  anesthesia. Blood was removed via cardiac puncture and the 
thoracic aorta was carefully extracted and placed in PSS. The aorta was then measured in 
a silicon-coated petri dish containing a ruler fastened to the bottom. The adhering fat and 
connective tissue were carefully removed from the vessel. The shape, length and any 
abnormalities of the aorta were documented. The vessel was cut into four rings, each 2-3 
mm in length using surgical scissors (George Tiemann & Co., Hauppauge, NY). With 
each animal, two of the rings were denuded and two were left intact for the experimental 
procedure. 
Denudation was achieved in two of the four aortic rings by gently rubbing the 
intima of the aortic ring with curved forceps on a PSS saturated paper towel. Figure 3.1 
illustrates the method utilized to achieve denudation. Denudation mimics the arterial 
injury that occurs in CVD. Furchgott and Zawadzki utilized the denudation method to 
discover the role, mechanism and factors influencing the pathway of EDRF/NO (1 16). 
These researchers determined that rabbit aortic vessels with an intact endothelium relaxed 
in the presence of acetylcholine. 
Figure 3.1: Method Used for Denudation 
Ring 
Endot helium removal 
Excerpted from Luscher & Vanhoutte (9). 
Whereas denuded aortic rings were not able to relax in the presence of EDRF/NO 
because the EDRF is released from the endothelium which is absent in denuded rings 
(1 16). In an intact endothelium, the contractile response of the a-adrenoreceptor is 
reduced because of the effect of NO to induce vasodilation (1 17). Disturbances in the 
production of EDRF/NO are commonly observed in atherolsclerotic animal models 
because of the presence of a dysfunctional endothelium. Consequently, the role of whole 
blueberries as a functional food, with respect to CVD, can only be evaluated and fully 
understood through an in vivo study investigating both intact and denuded arterial rings. 
The rings were passed through two stainless steel wires that were closed upon 
themselves to form two wire triangles (16, 117). The aortic rings were mounted in 
standard organ tissue baths containing PSS aerated with 95%02 15% C 0 2  (pH 7.45) and 
maintained at 37'C by a thermoregulator (16,20). One of the triangles was connected to 
a wire attached to a microprocessor based Tissue Force Analyzer (Micro-Med, 
Louisville, KY) while the other wire was attached to a glass hook in the tissue bath. The 
order the rings were placed in tissue baths was random. All rings from each animal were 
mounted in organ baths within 75 minutes from the administration of the anesthesia. 
The experimental design in its entirety is diagrammed in Figure 3.2. 
Figure 3.2: Experimental Design 
Blueberry (B) 7 tn 
Control (C) U/1 
Reverse (R) h 
n=8 per group 
I Denuded I 
I Denuded I 
I Intact I 
II Phenylephrine Dose Response Curve 11 
3.5 Tissue Equilibration and Experimental Protocol 
Following a 45 minute equilibration period under a 1.5 gram preload rings were 
preconditioned with the 17p1 of acetylcholine (Ach) and 17p1 of L-Phenylephrine 
(Phe) 1 0-3 for a period of 10 minutes followed by five washouts. Contraction of the rings 
was accomplished with six progressively higher doses of the alpha-1-adrenergic receptor- 
agonist Phe to 3 x lo-'). Administration of acetylcholine (3 x induces 
relaxation and was utilized to validate the presence or absence of an endothelial layer 
among the rings. Following a 25 minute wash out period a second Phe dose response 
curve was generated as previously described (1 1). 
The percent relaxation for each ring was assessed with the administration of the 
Ach dose. The exclusion criteria for the condition of the endothelium were determined 
by the percent relaxation observed in intact and denuded rings. Arterial rings with an 
intact endothelium demonstrated a relaxation between 85% and 100%. Intact arterial 
rings were excluded and considered to have a damaged endothelium if they relaxed less 
than 85%. Arterial rings without an endothelium did not show more than a 5% 
relaxation. Denuded arterial rings that exhibited an endothelium induced relaxation 
greater than 5% were excluded and determined to not have been successfully denuded 
(11, l6,2O, 117). 
Tension changes in the artery assessed by the tissue force analyzers were 
measured by a personal computer with system integrated software to generate digitalized 
raw data (DMSI-210, Micro-Med, Louisville, KY ). The digitalized raw data was used to 
generate individual dose response curves and the experimental parameters. The 
experimental parameters are presented in Table 3.4. Contraction and relaxation 
generated tension changes were used to generate the maximum contraction force (Fmax) 
value. The Fmax is indicative of the myogenic behavior and mechanical properties of 
each aortic ring and was used to determine the effect of the diet on the contractile 
machinery of the artery. ECso is the concentration of the fraction required to inhibit 50% 
of the vessel response. The ECso was obtained by transforming the dose response curves 
to semi-log curves. The pD2 value indicated the vessel sensitivity to each fraction of 
agonist added to the tissue bath. The pD2 value was calculated as the negative log (base 
10) of the EC50 value and serves as an indicator of receptor agonists interactions (1 6, 
1 17). 
Table 3.3: Experimental Parameters 
Experimental Parameter 
Fmax 
Biological Interpretation 
Maximum contraction and 
relaxation force of the 
vessel 
Contractile machinery 
Cell membrane receptor and 
vessel reactivity 
Vessel reactivity 
Ach dose required to inhibit 
50% of vessel response 
Assessment Method 
Dose response curve 
Negative log of ECso 
Semi-log transformations 
3.6 Statistical Analysis 
The Sigmastat Statistical Program Package (SAS Institute, Cary, NC) was used to 
conduct the statistical analysis. The values for Fmax and PD2 were presented as the mean 
* SE. The Fmax and PD2 value were each compared between diet groups with separate 
two-way analysis of variance (ANOVA) to detect the effect of diet. A three-way 
ANOVA was used to assess the differences between the intact and denuded rings with 
respect to different dietary treatments and the Student Newman Keuls (SNK) was used 
for multiple comparisons. Comparisons among animal body weights were conducted 
with standardized T-tests. Statistical significance was defined as a P value <0.05 (1 1, 16, 
20). 
CHAPTER 4 
RESULTS 
4.1 Rat Growth and Weights 
Figure 4.1 displays the rat growth curve. Animals on the B, C, and R diets all 
gained weight during the diet study. The rate of growth did not show a significant 
difference between the groups during the 13 week time period. The final mean body 
weights at the end of the 13 week period were 5 13 * 1 l g  for the C group, 522 * 7g for 
the B group and 508 * 9g for the R group. The final mean body weights between the 
three groups did not differ significantly at the end of the 13 week period @<0.05). 
1 2 3 4 5 6 7 8 9 10 11 12 13 1 
weeks 1 
4.2 Food Consumption 
The daily food intake among animals on a C, R and B diet was evaluated in the 
pilot study conducted in our laboratory during the previous year (1 1). Food intake per 
day did not differ significantly among diet groups over the course of the 13 week study. 
For the three groups, food intake steadily increased during the first five weeks and then 
steadily plateaued. No statistically significant differences were found in food intake 
among the three diet groups (See figure 4.2). 
Figure 4.2: Effect of Whole Wild Blueberries on Food Intake of Sprague-Dawley 
Rats 
time (weeks) 
LP 
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- 
4.3 Maximum Contraction Force (Fmax Value) 
4.3.1 Denuded and Intact Arterial Rings Maximum Contraction Force 
The mean maximum contraction force (Fmax) was evaluated in the denuded and 
intact arterial rings of all three diet groups and is presented in Table 4.1. The maximum 
contraction force that developed in response to phenylephrine was significantly different 
between the denuded and intact arterial rings. The intact arterial rings developed a 
significantly smaller contractile response, while the denuded arterial rings developed a 
larger contraction force (p<0.05) in response to phenylephrine. Mean Fmax among the 
intact arterial rings of the three diet groups was 0.969 h 0.00781 ; while among denuded 
arterial rings mean Fmax was 3.076 =k 0.00781 with statistically significant differences at 
~ ~ 0 . 0 5 .  
Table 4.1: Effect of Denudation on the Mean Maximum Contraction Force (Fmax) 
of Arterial Rings 
Arterial Ring Treatment 
Intact Arterial Rings 
I I 
(1) (2) Means between groups not having the same number are statistically significant at 
p<0.05. 
Fmax Value (grams) 
0.969 =k 0.0078 1''' 
Denuded Arterial Rings 3.076 h 0.00781'~' 
4.3.2 Intact Arterial Rings Maximum Contraction Force 
The effect of the diet on intact and denuded rings is presented in Table 4.2. The 
mean maximum contraction force that developed among the intact arterial rings of the 
control group was significantly larger than the mean maximum contraction force that 
developed among the intact rings of the blueberry and reverse groups ( ~ ~ 0 . 0 5 ) .  The 
mean Fmax observed among the control group's intact arterial rings (1.109 i 0.0463) 
was significantly different than the mean Fmax observed in the intact rings of both the 
reverse (0.926 * 0.0463) and blueberry (0.873 * 0.0463) groups ( ~ ~ 0 . 0 5 ) .  Thus, the 
intact arterial rings of the blueberry and reverse groups developed a significantly smaller 
contraction force when challenged with the L-phenylpherine compared to the control 
group (p<0.05). Additionally, the Fmax of the blueberry group's intact arterial rings 
tended to be lower than the reverse group's intact arterial rings but did not reach 
statistical significance (p<0.05). Figure 4.3 graphically depicts the mean maximum 
contraction force of the intact arterial rings. 
Table 4.2: Effect of Whole Wild Blueberries on the Mean Maximum Contraction 
Force (Fmax) of Intact Arterial Rings 
1 Diet Group I Fmax Value (grams) 
Control Group 
(1) (2) Means between groups not having the same number are statistically significant at 
p<0.05. 
1.109 * 0.0463 ' I '  
Blueberry Group 
Reverse Group 
0.873 * 0.0463 "' 
0.926 * 0.0463 "' 
Figure 4.3: Effect of Whole Wild Blueberries on the Mean Maximum Contraction 
Force (Fmax) of Intact Arterial Rings 
I €I Blueberry BControl OReverse I 
*Statistically significant at p<0.05. 
4.3.3 Denuded Arterial Rings Maximum Contraction Force 
The mean Fmax of the denuded arterial rings from the blueberry, control, and 
reverse diet groups are presented in Table 4.3. The mean Fmax developed by the 
denuded arterial rings of the control, blueberry and reverse groups were 3.065 * 0.0580, 
3.185 h 0.0580 and 2.977 h 0.0580 respectively. No statistically significant differences 
in Fmax among the denuded arterial rings were observed (p<0.05). Figure 4.4 presents 
graphically the effect of diet on the Fmax of denuded arterial rings. 
Table 4.3: Effect of Whole Wild Blueberries on the Mean Maximum Contraction 
Force (Fmax) of Denuded Arterial Rings 
Diet Group 
1 Reverse Group 1 2.977 * 0.0580 I 
Fmax Value (grams) 
Blueberry Group 
Means are not statistically significant at p<0.05. 
3.185 * 0.0580 
Figure 4.4: Effect of Whole Wild Blueberries on the Mean Maximum Contraction 
Force (Fmax) of Denuded Arterial Rings 
Not statistically significant at ~ ~ 0 . 0 5 .  
4.4 Vessel Sensitivity: pD2 Values 
4.4.1 Denuded and Intact Arterial Rings Vessel Sensitivity 
The pD2 value is a measure of vessel sensitivity to the alpha-adrenergic receptor for each 
phenylephrine dose. Vessel sensitivity indicates the membrane receptor conformational 
changes that occurred for each phenylephrine dose. Table 4.4 presents the pD2 values for 
the intact and denuded arterial rings. The pD2 value for the denuded arterial rings (7.471 
* 0.00451) was significantly higher than the pD2 value for the intact arterial rings (6.776 
* 0.00451) at p<0.05. 
Table 4.4: Effect of Denudation on the Mean pD2 of Arterial Rings 
Arterial Ring Treatment 1 Vessel Sensitivity: pD2 Value 
Intact Arterial Rings 
(1) (2) Means between groups not having the same number are statistically significant at 
p<0.05. 
6.776 * 0.00451"' 
Denuded Arterial Rings 
4.4.2 Intact Arterial Rings Vessel Sensitivity 
Table 4.5 and Figure 4.6 display the mean pD2 values observed among the intact arterial 
rings. The mean pD2 values for the intact arterial rings of the blueberry (6.751 * 0.0791), 
control (6.715 * 0.0791) and reverse (6.864 * 0.0791) diet groups did not differ 
significantly from each other (p<0.05) . 
7.471 * 0.0045 1'2) 
Table 4.5: Effect of Whole Wild Blueberries on the Mean pD2 of the Intact Arterial 
Rings 
Diet Group Vessel Sensitivity: pD2 Value 
Control Group 6.715 i 0.0791 
Blueberry Group 
I I 
Means are not statistically significant at p<0.05. 
6.751 * 0.0791 
Reverse Group 
Figure 4.5: Effect of Whole Wild Blueberries on the Mean pD2 of Intact Arterial 
6.864 i 0.0791 
Rings 
B Blueberry Control @!I Reverse 
Not statistically significant at p<0.05. 
4.4.3 Denuded Arterial Rings Vessel Sensitivity 
Table 4.5 and Figure 4.6 display the mean pD2 values observed among the denuded 
arterial rings. The mean pD2 values for the denuded arterial rings of the blueberry (7.548 
* 0.0509), control (7.426 * 0.0509) and reverse (7.440 * 0.0509) groups did not differ 
significantly from each other (p<0.05). 
Table 4.6: Effect of Whole Wild Blueberries on the Mean pD2 of Denuded Arterial 
Rings 
I Blueberry Group 1 7.548 * 0.0509 I 
Diet Group 
Control Group 
Vessel Sensitivity: pD2 Value 
7.426 * 0.0509 
Means are not statistically significant at p<0.05. 
Reverse Group 7.440 * 0.0509 
62 
Figure 4.6: Effect of Whole Wild Blueberries on the Mean pDz of Denuded Arterial 
Rings 
H Blueberry El  Control IUl Reverse 
Not statistically significant at p<0.05. 
CHAPTER 5 
DISCUSSION 
5.1 Overall Results 
The objective of the present study was to evaluate the in vivo dietary effect of 
whole wild blueberries on the biomechanical properties of the Sprague-Dawley rat aorta 
as related to cardiovascular disease. Our results demonstrate for the first time that whole 
wild blueberries affect the vascular contractile machinery causing a decrease in the mean 
maximum contraction force (Fmax) in response to the contractile effect of the alpha-l- 
adrenoreceptor agonist L-phenylephrine (PE). These results indicate that blueberries 
require a functional endothelium to exert their effect on the vascular contractile 
machinery. However, based on the results from vessel reactivity index, pD2, blueberries 
most likely do not function through cell membrane receptor-agonist interactions. The 
effect of blueberries to improve arterial integrity, decrease vasoconstriction and reduce 
vascular resistance has implications for blood pressure regulation and overall 
cardiovascular health. Cardiovascular disease (CVD) continues to claim more lives each 
year in developed countries than any other disease. An alarming fact is that, only 30% of 
the morbidity associated with CVD can be attributed to the traditional risk factors. 
Consequently, the observed cardiovascular benefit of whole wild blueberries could 
provide a therapeutic mechanism for the maintenance of arterial health and the prevention 
of a dysfunctional endothelium. 
The endothelium plays a central role in the pathogenesis of cardiovascular disease 
(5, 8). By modulating the arterial damage when individuals are exposed to stress or risk 
factors for atherosclerosis. Endothelial dysfunction, one of the earliest stages in 
atherosclerosis, impairs the release and action of vasoactive substances and precedes the 
morphological changes of the arterial wall (8, 9). The dysfunctional endothelium, created 
by mechanically removing the intima, mimics the endothelium damage that occurs with 
atherosclerosis. The alpha-adrenergic receptors of the endothelial cells produce 
vasoconstrictor and vasorelaxing factors in response to stimuli (1 17). Vasoacitve 
substances produced by a functional endothelium exert their action on the VSMC or the 
endothelium to elicit a contraction or relaxation. Consequently, Kawabe et al. proposes 
that the alpha-adrenergic receptors may allow for endothelial cell regulation of the 
VSMC contraction (1 17). VSMC regulation via the alpha-adrenergic receptors could 
prevent complete closure of the vasculature (1 17). The endothelium is also critical for 
the vessel relaxation induced by other vasoactive substances including bradykinin, 
substance P, histamine, serotonin and arachidonic acid (12). 
The role of denudation is to remove the functional endothelial layer responsible 
for the production of vasoactive substances. A dysfunctional endothelium is unable to 
modulate the balance of endothelium-dependent vasorelaxation and contraction that is 
required to maintain vascular integrity (5, 9). Thus the effect of denudation allowed us to 
elucidate where blueberries act to affect the VSMC or the endothelium of the artery. 
Impairment of endothelium-dependent NO arterial relaxation occurs with a 
dysfunctional endothelium in the early stages of atherosclerosisis (1 18). Nitric oxide, a 
vasodilator, functions to inhibit VSMC contraction. Thus, a possible physiological 
influence of NO includes regulating blood pressure by affecting vasoconstriction of the 
vessel (22). The endothelial-dependent vasorelaxation, stimulated by increases in the 
CAMP-NO system is impaired with a dysfunctional endothelium. Thus, the 
bioavailability of NO may be responsible for the impaired VSMC function that occurs 
with a dysfunctional endothelium (16, 117). Numerous studies have documented the 
beneficial effects of NO, including: vasodilation, inhibition of vasoconstriction, inhibition 
of platelet adhesion, inhibition of leukocyte adhesion, reduction of smooth muscle cell 
proliferation, and the scavenging of superoxide anions (9, 12,43). Therefore, reduced 
NO production, occurring with a dysfunctional endothelium, is instrumental in the 
progression of cardiovascular disease. 
5.2 Effect of Denudation 
The effectiveness of denudation was evaluated with the effect of acetylcholine on 
each arterial ring. Furchgott and Zawadzki determined that acetylcholine requires the 
endothelium to cause arterial vasorelaxation (1 16). Thus, endothelial denudation was 
confirmed with the application of an acetylcholine dose and subsequent lack of vessel 
relaxation. In our study, the denuded arterial rings had an increased maximum 
contraction force (Fmax) compared to the intact rings. The observed contractile ability of 
the denuded rings' VSMCs indicates that the integrity of the contractile machinery was 
not compromised during the mechanical denudation procedure. In addition, the denuded 
rings displayed less than 5 % relaxation upon exposure to the acetylcholine dose. Our 
results are in agreement with Adeagbo et al. who observed acetylcholine-induced 
relaxation of intact rings and no relaxation among the denuded rings (27). Acetylcholine 
exerts its effect through an indirect mechanism involving endothelium derived relaxing 
factor (NO) that diffuses from the endothelium to the VSMC (16). In addition, 
acetylcholine mediated vasodilation can occur through NO, PGI2, and EDHF (1 17). Our 
results validate that our denudation procedure effectively removed the endothelial layer 
of the denuded arterial rings without damaging the VSMC layer. 
In our animals, the maximum contraction force (Fmax) developed in response to 
L-phenylephrine agonist was increased among the animals with denuded arterial rings 
compared to animals with intact arterial rings. The effect of denudation increases the 
concentration of receptor sites available for alpha- 1- agonists binding (27). Thus the 
absence of the endothelium enhances the contraction, via binding of L-phenylephrine to 
VSMC alpha-1 -adrenoceptors (1 19). The structural integrity of the denuded rings was 
confirmed with the expected absence of relaxation upon application of an acetylcholine 
dose. It has been known for some time that endothelium-derived nitric oxide (NO) 
mediates vascular relaxation (27). Endothelial dysfunction impairs the production and 
release of endothelium-dependent vasodilating substances (i.e NO) to cause vessel 
relaxation. Thus the endothelium-denuded vessels prevented the endothelium from 
functioning as a modulator of vasoconstriction and vasodilation (1 18). As expected, we 
observed a reduced Fmax to PHE among the endothelium-intact arterial rings. The 
presence of a functional endothelium among the intact rings, reduces the concentration of 
receptor sites for PHE to bind, because the endothelial layer lines the vessel and prevents 
direct exposure of the VSMC to the agonists. 
Vessel reactivity, pDz, is an index of membrane receptor agonist interactions 
which in this study indicates whether bluebemes act to affect the pathway of the agonist. 
Vessel reactivity is derived from the ECSo. The ECso is the concentration of the agonist 
fraction required to inhibit 50% of the vessel response. The ECso was obtained by 
transforming the dose response curves to semi-log curves (120). The pD2 value was 
calculated as the negative log (base 10) of the EC50 value and serves as an indicator of 
receptor agonists interactions and vessel sensitivity to each fraction of agonist added to 
each tissue bath. As expected, differences were observed in the pD2 value between 
intact and denuded arterial rings (1 17). The reduction that we observed in the pD2 of 
intact arterial rings suggests a depressed membrane-related effect of receptor agonist 
interactions. The observed increased pD2 value of denuded arterial rings occurs because 
of the increased receptor-agonist interactions occurring in the absence of the endothelial 
cell layer (1 6, 1 17). With the removal of the endothelium, agonist receptors on the 
VSMC are exposed and present in a higher concentration which allows an increased 
binding and action of agonists. 
5.3 Effect of Diet 
This is the first study to document the in vivo effect of whole wild blueberries on 
the biomechanical properties of the artery of Sprague-Dawley rats. Among the intact 
arterial rings, blueberries decreased the Fmax to PHE when compared to their effect on 
the control animals. The differences in Fmax between the blueberry and control group's 
intact arterial rings indicate that blueberries function on the vascular contractile 
machinery of the artery. Our results also demonstrated for the first time a reduced 
maximum contraction force to PHE between the intact rings of the reverse and the control 
diet groups. This suggests that the addition of blueberries to older animals may be 
beneficial in maintaining endothelial function and regulating vascular tone. The reverse 
diet group consisted of animals consuming the control diet for thirteen weeks and then 
the blueberry diet for eight weeks. Additionaly, there were no differences in the 
maximum contraction force to PHE between the blueberry and reverse diet groups. 
Consequently, these results indicate that blueberries can function to reduce the maximum 
contraction force to PHE among animals that had previously consumed a diet without 
blueberries. Our results suggest that blueberries require a functional endothelium in 
order to affect the biomechanical properties of the aorta. In addition, the present study 
indicates that blueberries could function to not only maintain but also to improve arterial 
integrity of older animals. 
Our results are supported by the in vitro observation that blueberry extract, 
enriched with anthocyanins, functioned to cause endothelial-NO dependent relaxation of 
the rat aorta (1 2 1, 105). Even though our results are the first to evaluate dietary 
consumption and the corresponding effect of whole blueberries on arterial function, other 
anthocyanin containing foods have been evaluated. The effects of red wine polyphenolic 
compounds (RWPC) on endothelial function have received considerable attention by 
researchers. Andriambeloson et al. observed the in vitro effect of red wine polyphenolic 
compounds (RWPC) on the endothelium to induce endothelium-dependent 
vasorelaxation (106). Andriambeloson et al. concluded that the effect of RWPC to 
induce vasorelaxation is associated with an enhancement of the NO-cGMP system rather 
than the ability of RWPC to protect NO from breakdown (105, 107). In addition, red- 
wine improved arterial health by preventing homocysteine from decreasing eNOS levels 
and resulting in endothelial dysfunction (121). 
We did not observe differences in the vessel reactivity (pDz) of the intact arterial 
rings between the control, reverse or blueberry groups. This suggests that the ability of 
the blueberry diet to affect the vascular tone of the artery does not involve interactions 
between agonist membrane receptors and blueberry components. In addition, there were 
no differences among the denuded arterial rings from the different diets that affected the 
membrane-receptor agonist interactions. These results further suggest that the effect of 
blueberries does not involve membrane-receptor agonists on the VSMC. 
Most likely, bluebemes' effect of the vascular contractile machinery requires the 
presence of a functional endothelium, as indicated by differences in Fmax, but does not 
involve membrane-receptor agonist interactions on the endothelium or VSMC. Our 
results suggest for the first time that whole wild blueberries, as a component of the diet, 
may be capable of improving the arterial integrity by affecting the vascular contractile 
machinery of the artery when challenged with PHE. 
An effect of diet was not observed among the denuded arterial rings from the 
three dietary groups. Hence, the observed maximum contraction force and vessel 
reactivity of the endothelial-denuded arterial rings from the blueberry, control, or reverse 
diet groups were not significantly different. As previously stated, differences were 
observed in vessel reactivity between the intact and denuded rings within each diet group. 
Thus, the mechanism by which bluebemes elicit an effect on the aortic VSMC contractile 
machinery to improve arterial integrity requires the presence of a functional endothelium. 
These results indicate that although bluebemes do not have membrane-related effects of 
receptor-agonist interactions, they function through a pathway in the endothelium to 
ultimately affect the vascular contractile machinery of the artery. Thus the mechanism by 
which blueberries may act to reduce arterial contraction in response to alpha-1 -adrenergic 
agonist could occur through a pathway such as NO or CAMP that requires an intact 
endothelial layer. 
5.4 Blueberry Components 
This is the first time an in vivo effect of diet with whole wild blueberries on the 
endothelium has been observed. Previous studies have evaluated the in vitro effect of 
both blueberry and other polyphenolic components on endothelial function. Potentially, 
the polyphenolic components eliciting the vessel relaxation may also function to reduce 
the vessel contraction by preserving NO. Of the 17 known anthocyanins, only 6 are 
found in higher plant forms and 5 of these anthocyanins are found in the blueberry. The 
five anthocyanins identified in whole wild blueberries, delphinidin, malvidin, petunidin, 
cyanidin and peonidin, are shown in figure 2.3 and table 2.2 (54, 122). The results of our 
dietary study indicate the in vivo effects of the whole wild blueberry on the endothelium. 
On the other hand, previous studies evaluated the in vitro beneficial cardiovascular effect 
of individual anthocyanin extracts from blueberries and other polyphenolic containing 
foods. RWPC extracts, malvidin and cyanidin did not induce endothelium-dependent 
relaxtion, while delphinidin induced endothelial vasorelaxation was completely mediated 
by NO (105). The location of the hydroxyl group on the anthocyanin may influence its 
antioxidant and antiproliferative activity (71). Consequently, the hydroxyl group position 
may also influence its ability to induce endothelial vasorelaxation (123). The increased 
synthesis of NO observed by Andriambeloson et al. may partially explain how 
polyphenolic compounds of whole wild blueberries in our study reduced vasocontraction. 
However, the results we observed reflect the bioavailability of the whole wild blueberry 
in addition to the synergistic effects of its components on the endothelium. 
The in vitro cardioprotective mechanism of polyphenolic compounds may be 
associated with the elicited endothelial NO dependent relaxation. Peroxynitrite is a toxic 
oxidant, formed from the reaction of NO and superoxide anion. Cyanidin-3-0-glucoside 
(C3G) extract from blackberries, displayed an in vitro protective effect against 
endothelial dysfunction by scavenging peroxynitrite in human umbilical vein endothelial 
cells (124). Therefore, cyanidin-3-0-glucoside may be capable of improving the 
bioavailability of NO. Enhanced endothelial NO-synthase-mediated relaxation was 
observed in internal mammary aortic rings following pre-incubation with procyanidins 
from grape seed extract. The procyanidins protected the endothelial cells from 
peroxynitrite damage and increased endothelium-dependent relaxation. Thus, this study 
supports the possibility that structurally related anthocyanin compounds affect the NO 
and influence the endothelium (125). 
Intact aortic rings exposed to RWPC displayed an increase in cGMP formation 
(106). Delphinidin produced the same profile as the RWPC and is also one of the five 
anthocyanins in blueberries (54, 105). The possible role of the involvement of the NO- 
cGMP system is reinforced by the fact that blueberry extracts enriched with anthocyanins 
caused an NO-endothelial dependent relaxation of rat aorta (106). The effect of 
anthocyanins on the NO is further evidenced by the ability of anthocyanins to increase 
the activity of NO synthase and cause relaxation of the aortic rings (107). Thus, 
blueberries act on the endothelium to affect a pathway in the VSMC possibly by affecting 
the NO-cGMP system. 
5.5 Hypothetical Mechanism 
The results of our in vivo study are reinforced by the in vitro observations 
previously stated. Although the beneficial cardiovascular mechanism of whole wild 
blueberries is unknown, endothelium-dependent vasocontraction and vasorelaxation may 
be attributed to the enhanced synthesis of NO. We hypothesize that a mechanism 
involving enhanced NO production or increased NO bioavailability may be responsible 
for the reduced maximum contraction force observed among the blueberry groups intact 
rings in our study. The pathway for NO production, as depicted in Figure 2.2, involves 
the guanylate cyclase catalyzing the formation of cGMP. Increased formation of cGMP, 
causes smooth muscle relaxation via protein kinase phosphorylation. Continued stimulus 
of the endothelial cells may increase in cGMP and cause a relaxation response of the 
VSMC (107). Nitric oxide functions to activate VSMC guanylate cyclase, produce 
CAMP, cause vasodilation locally and may also be deactivated by superoxide and other 
02- free radicals (12). Red wine increased endothelial NOS activity in human endothelial 
cells in vitro (126). Duarte et a1 investigated the effect of flavonoids on rat aortic smooth 
muscle and revealed that a possible mechanism of flavonoids involved the reduction of 
cGMP breakdown by inhibiting cyclic nucleotide phosphodiesterases (127). Activation 
of phsopholipase C, phospholipase A, protein kinase C, and tyrosine kinase are not 
involved in the endothelial NO-dependent vasorelaxation induced by wine polyphenols in 
the rat thoracic aorta (128). Nitric oxide bioavailability is based upon intracellular 
availability of L-arginine, altered NOS activity (eNOS or iNOS), impaired receptor 
mediated release of NO and generation of reactive oxygen species (12). Thus, the 
preservation of NO or increased production of NO may occur through several 
mechanisms and affect the contractile machinery of the VSMC. The increased 
bioavailability of NO could be responsible for the effect of whole wild blueberries on the 
endothelium. 
Numerous studies have documented the absorption and metabolism of 
anthocyanins from the blueberry to increase the serum antioxidant status (58,63, 113). 
The absorption of polyphenols by human subjects was detected by Paganga and Rice- 
Evans to increase polyphenolic plasma concentration to 0.5-1.6 pmol. The plasma 
concentration detected was comparable to the polyphenolic concentration required to 
induce 50% of the vessel maximal relaxation (62). Youdim et al. determined that 
anthocyanins extracted from the elderberry can be incorporated into the endothelial cell's 
cytosol and membrane to enhance resistance to reactive oxygen species in vitro (97). 
These studies confirm the absorption and incorporation of anthocyanins in humans and 
suggest the bioavailability of anthocyanins allows a concentration to provide an in vivo 
effect. Furthermore, based on these studies on absorption and incorporation of berry 
anthocyanins, we hypothesize that the effect of whole wild blueberries observed in the 
Sprague-Dawley rat aorta may also be observed in humans to improve arterial integrity 
and possibly cardiovascular function. 
5.6 Clinical Relevance 
Blueberries and other polyphenolic containing fruits have been recognized as 
having various health benefit's in protecting against chronic diseases including; 
preventing glaucoma, fibrocystic disease of the breast in humans, cancer, cerebrovascular 
conditions, diabetes, atherosclerosis, and cardiovascular disease (30). Blueberries have 
the highest polyphenolic content of all fruits and vegetables (48,49). Investigators have 
also observed a direct correlation between polyphenolic content and antioxidant 
properties of blueberries (48,49). Our results confirm that whole wild blueberry 
components are bioavailable and can elicit an in vivo effect on endothelial function. The 
present study indicates that blueberries aid in arterial relaxation by acting on the 
vasodilator tone of the artery. In addition to improved vasorelaxation, studies have 
documented blueberries and blueberry component benefits on the cardiovascular include; 
reduced capillary permeability, decreased platelet aggregation and leukocyte adhesion, 
increased arterial flexibility, inhibition of oxidation and Maillard reactions and reduced 
inflammation (68). Thus far, blueberries have been implicated to be beneficial in 
preventing the progression of atherosclerosis and for improving cardiovascular health 
through various mechanisms. The vast majority of studies have been conducted in vitro. 
Hypertension (high blood pressure) is a known risk factor for the development of 
atherosclerosis. The arteries of hypertensive individuals have increased vascular tone, 
increased vasoconstriction and a reduced a vascular response to sheer stress (129). 
Pomegrantate juice was shown to have an inhibitory effect on serum angiotensin 
converting enzyme (ACE) levels and to slightly reduce the blood pressure of 
hypertensive patients after two weeks of consumption (130). Our results indicate that 
blueberries act through NO to affect the vascular tone of the artery. The vasorelaxant 
effect that blueberries appear to be capable of elliciting in arteries could have 
implications on blood pressure regulation. Furthermore, whole wild blueberries could 
have therapeutic implications for blood pressure regulation. 
5.7 Conclusion 
This is the first study to identify the role of whole wild blueberries and the 
location of their effect on the vascular endothelium. In addition, this is the first dietary 
study evaluating the possible implications whole wild blueberries could have on 
endothelial function as related to cardiovascular disease. Our results confirm that 
sufficient absorption of the whole blueberries occurred to create an in vivo effect. This 
study determined that whole wild blueberries affect the vascular contractile machinery of 
the rat aorta to reduce the maximum contraction force generated in response to the alpha- 
1 -adrenergic agonist L-phenylephrin in vivo. Blueberries do not affect vessel reactivity 
as indicated by the pDz value. They seem to act on the VSMC through the endothelium 
and may involve the NO-cGMP system. Our results indicate that blueberries can 
improve arterial integrity and alter the responsiveness of the artery to factors such as high 
blood pressure or other factors increasing vessel contractility and predisposing the 
cardiovascular system to CVD. This suggests that blueberries improve the vascular tone 
of the artery. Consequently, whole wild blueberries may have implications in blood 
pressure regulation and could prove to have a therapeutic role in improving 
cardiovascular health. 
5.8 Limitations and Future Recommendations 
The majority of studies conducted thus far on the vasorelaxant benefits of 
polyphenolic compounds with reference to cardiovascular health have focused on RWPC. 
Although blueberries and red wine have a similar polyphenolic profile they do have 
significant differences. This study served the purpose of identifying the location of the 
action of blueberries on the artery and allowed us to speculate the mechanism of 
blueberries action involving NO to be proposed. Further studies are needed to identify 
the pathways that whole wild blueberries functionto affect the contractile machinery of 
the aorta. Studies are also needed to elucidate the dietary effectiveness of individual 
blueberry extracts in comparison to the dietary effect of whole wild blueberries on the 
aortic vascular contractile machinery. For instance, delphinidin, an anthocyanin common 
to red wine and blueberries, was documented as producing a vasorelaxant effect 
comparable to red wine. It is unknown if the benefit of the whole blueberry or what 
combination of polyphenolic compounds or individual anthocyanins are responsible for 
the vasorelaxant effect observed in this study. In addition, studies in other animal models 
are required to evaluate the dietary effect of whole wild blueberries on the endothelium 
and VSCM. An investigation should also be conducted to evaluate the possible role of 
whole wild blueberries on blood pressure regulation. The hypertensive rat would be an 
ideal model to evaluate the dietary effect of whole wild blueberries on blood pressure 
regulation. Another study would be to evaluate the effect of whole bluebemy 
consumption within a population of hypertensive human subjects. It is apparent that 
based on our in vivo observations; there are numerous avenues a researcher could select 
to better understand the pathway blueberries utilize to affect the endothelium as related to 
cardiovascular health. Hopefully, the consumption of whole wild blueberries will prove 
to be an alternative therapeutic modality for improving endothelial function and overall 
cardiovascular health. 
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